Please Subscribe to get a daily link to Pat's blog via email

Subscribe!

Your privacy is important to us. We will never spam you and keep your personal data secure.

Why Research From ASCO Is So Important For Multiple Myeloma Patients: Attacking Multiple Pathways

Home/Why Research From ASCO Is So Important For Multiple Myeloma Patients: Attacking Multiple Pathways

Why Research From ASCO Is So Important For Multiple Myeloma Patients: Attacking Multiple Pathways

Here is a link to an excellent video, featuring Dr. Kenneth Anderson from the Dana-Farber Cancer Institute, Boston, Massachusetts, I found on a clinician’s Website, Managing Myeloma:

Attacking Multiple Pathways To Stop Multiple Myeloma

Dr. Anderson’s audio is playing while I write this article–perfect for busy multi-taskers.  In his presentation, Dr. Anderson reviews research results, presented at ASCO in Chicago in June.  He then goes into great detail, explaining why drug combinations that attack multiple pathways, show so much promise and work so well against multiple myeloma.

Feel good and keep smiling!  Pat